{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:20:10Z","timestamp":1790382010535,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ijid.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T02:35:53Z","timestamp":1597199753000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis"],"prefix":"10.1016","volume":"99","author":[{"given":"Osagie A.","family":"Eribo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monkoe S.","family":"Leqheka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanus T.","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"McAnda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian D.","family":"van der Spuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novel N.","family":"Chegou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijid.2020.08.019_bib0005","first-page":"539","article-title":"Urine test for tuberculosis in development","volume":"319","author":"Abbasi","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/13993003.00543-2016","article-title":"Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: what lessons have we learnt and how can we do better?","volume":"48","author":"Albert","year":"2016","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ijid.2020.08.019_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gpb.2015.08.005","article-title":"Urinary biomarkers of brain diseases","volume":"13","author":"An","year":"2015","journal-title":"Genomics Proteomics Bioinform"},{"issue":"3","key":"10.1016\/j.ijid.2020.08.019_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jinf.2016.04.036","article-title":"Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease","volume":"73","author":"Awoniyi","year":"2016","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jcm9010111","article-title":"Point-of-care urine LAM tests for tuberculosis diagnosis: a status update","volume":"9","author":"Bulterys","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2334-10-333","article-title":"IP-10 detection in urine is associated with lung diseases","volume":"10","author":"Cannas","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.ijid.2020.08.019_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/eri.11.23","article-title":"Tuberculosis assays: past, present and future","volume":"9","author":"Chegou","year":"2011","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"9","key":"10.1016\/j.ijid.2020.08.019_bib0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/thoraxjnl-2015-207999","article-title":"Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB","volume":"71","author":"Chegou","year":"2016","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-20855-7","article-title":"Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis","volume":"8","author":"Chegou","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0055","first-page":"1","article-title":"Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach","volume":"10","author":"Cho","year":"2020","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10.1016\/j.ijid.2020.08.019_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clinbiochem.2015.08.013","article-title":"Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa","volume":"49","author":"Corstjens","year":"2016","journal-title":"Clin Biochem"},{"issue":"11","key":"10.1016\/j.ijid.2020.08.019_bib0065","first-page":"1226","article-title":"The diagnosis and misdiagnosis of tuberculosis [State of the art series, Tuberculosis. Edited by ID Rusen. Number 1 in the series]","volume":"12","author":"Davies","year":"2008","journal-title":"Int J Tubercul Lung Dis"},{"issue":"4","key":"10.1016\/j.ijid.2020.08.019_bib0070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biometrical J"},{"issue":"5","key":"10.1016\/j.ijid.2020.08.019_bib0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/resp.13272","article-title":"Update on tuberculosis biomarkers: from correlates of risk to correlates of active disease and of cure from disease","volume":"23","author":"Goletti","year":"2018","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0080","doi-asserted-by":"crossref","DOI":"10.4081\/idr.2016.6568","article-title":"Tuberculosis biomarkers: from diagnosis to protection","volume":"8","author":"Goletti","year":"2016","journal-title":"Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.ijid.2020.08.019_bib0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0090","doi-asserted-by":"crossref","first-page":"AB357","DOI":"10.1016\/j.jaci.2010.01.010","article-title":"Serum levels of soluble IL6R are genetically regulated and correlate with lung function in asthmatics: Severe Asthma Research Program (SARP)","volume":"125","author":"Hawkins","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.ijid.2020.08.019_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002792","article-title":"Diagnostic value of the urine lipoarabinomannan assay in HIV-positive ambulatory patients with CD4 below 200 cells\/\u03bcl in 2 low-resource settings: a prospective observational study","volume":"16","author":"Huerga","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2020.08.019_bib0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2018.04.014","article-title":"Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis","volume":"31","author":"Isa","year":"2018","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ijid.2020.08.019_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160546","article-title":"Diagnostic potential of novel salivary host biomarkers as candidates for the immunological diagnosis of tuberculosis disease and monitoring of tuberculosis treatment response","volume":"11","author":"Jacobs","year":"2016","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.ijid.2020.08.019_bib0110","doi-asserted-by":"crossref","first-page":"57581","DOI":"10.18632\/oncotarget.11420","article-title":"Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response","volume":"7","author":"Jacobs","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijid.2020.08.019_bib0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cyto.2016.02.004","article-title":"Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment","volume":"81","author":"Jacobs","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ijid.2020.08.019_bib0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fimmu.2020.00419","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases are potential biomarkers of pulmonary and extra-pulmonary tuberculosis","volume":"11","author":"Kathamuthu","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12879-018-3144-3","article-title":"Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1515\/cclm-2016-0840","article-title":"Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance","volume":"55","author":"Kust\u00e1n","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.ijid.2020.08.019_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192664","article-title":"Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary non tuberculosis disease","volume":"13","author":"La Manna","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0140","first-page":"331","article-title":"The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer","volume":"6","author":"Li","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"4","key":"10.1016\/j.ijid.2020.08.019_bib0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","article-title":"Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection","volume":"78","author":"Luo","year":"2019","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.ijid.2020.08.019_bib0150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41564-019-0380-2","article-title":"A systematic review of biomarkers to detect active tuberculosis","volume":"4","author":"MacLean","year":"2019","journal-title":"Nat Microbiol"},{"issue":"8","key":"10.1016\/j.ijid.2020.08.019_bib0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/cas.12187","article-title":"Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy","volume":"104","author":"Makuuchi","year":"2013","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.ijid.2020.08.019_bib0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jinf.2019.07.007","article-title":"Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals","volume":"79","author":"Manngo","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2020.08.019_bib0165","first-page":"2019","article-title":"Application of cerebrospinal fluid host protein biosignatures in the diagnosis of tuberculous meningitis in children from a high burden setting","author":"Manyelo","year":"2019","journal-title":"Mediat Inflamm"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50791-z","article-title":"MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease","volume":"9","author":"Medeiros","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ijid.2020.08.019_bib0175","doi-asserted-by":"crossref","first-page":"e22100","DOI":"10.1002\/jcla.22100","article-title":"Relationship between serum cytokines receptors and matrix metalloproteinase 9 levels and coronary artery disease","volume":"31","author":"Mirhafez","year":"2017","journal-title":"J Clin Lab Anal"},{"issue":"23","key":"10.1016\/j.ijid.2020.08.019_bib0180","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6 secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Nilsson","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ijid.2020.08.019_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.ijid.2020.08.019_bib0190","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1183\/09031936.00147912","article-title":"Xpert MTB\/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis","volume":"42","author":"Pantoja","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijid.2020.08.019_bib0195","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1183\/09031936.00201711","article-title":"Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients","volume":"40","author":"Peter","year":"2012","journal-title":"Eur Respir J"},{"issue":"10024","key":"10.1016\/j.ijid.2020.08.019_bib0200","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","article-title":"Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic parallel-group multicountry open-label randomised controlled trial","volume":"387","author":"Peter","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.08.019_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2018.09.001","article-title":"First description of agonist and antagonist IP-10 in urine of patients with active TB","volume":"78","author":"Petrone","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2020.08.019_bib0210","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.5588\/ijtld.16.0342","article-title":"Blood and urine inducible protein 10 as potential markers of disease activity","volume":"20","author":"Petrone","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.ijid.2020.08.019_bib0215","doi-asserted-by":"crossref","first-page":"101859","DOI":"10.1016\/j.tube.2019.101859","article-title":"Distinct serum biosignatures are associated with different tuberculosis treatment outcomes","volume":"118","author":"Ronacher","year":"2019","journal-title":"Tuberculosis"},{"issue":"24","key":"10.1016\/j.ijid.2020.08.019_bib0220","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/jnci\/djt309","article-title":"Circulating inflammation markers and prospective risk for lung cancer","volume":"105","author":"Shiels","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijid.2020.08.019_bib0225","series-title":"Lateral flow urine lipoarabinomannan assay for diagnosis of active tuberculosis in adults with human immunodeficiency virus infection: a prospective cohort study. Open forum infectious diseases","first-page":"ofz132","author":"Songkhla","year":"2019"},{"issue":"5","key":"10.1016\/j.ijid.2020.08.019_bib0230","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1186\/cc10508","article-title":"Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study","volume":"15","author":"Su","year":"2011","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.ijid.2020.08.019_bib0235","first-page":"720","article-title":"Levels of interferon-\u03b3 and interleukin-2 receptor-\u03b1 for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis","volume":"6","author":"Tsao","year":"2002","journal-title":"Int J Tubercul Lung Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0240","first-page":"122","article-title":"Biological role of the soluble interleukin-2 receptor in sarcoidosis","volume":"34","author":"Vanmaris","year":"2017","journal-title":"Sarcoidosis Vasculitis Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0245","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2015.04.014","article-title":"Circulating levels of interleukin 6 soluble receptor and its natural antagonist sgp130 and the risk of myocardial infarction","volume":"240","author":"Vel\u00e1squez","year":"2015","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.ijid.2020.08.019_bib0250","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1128\/JVI.01248-13","article-title":"Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses","volume":"87","author":"Wang","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2020.08.019_bib0255","series-title":"IL-18\/IL-37\/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB 14(12)","author":"Wawrocki","year":"2019"},{"key":"10.1016\/j.ijid.2020.08.019_bib0260","series-title":"Use of tuberculosis interferon-gamma release assays (IGRAs) in low-and middle-income countries: policy statement","author":"WHO","year":"2011"},{"key":"10.1016\/j.ijid.2020.08.019_bib0265","series-title":"High priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting, 28\u201329 April 2014","author":"WHO","year":"2014"},{"key":"10.1016\/j.ijid.2020.08.019_bib0270","series-title":"The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV: policy guidance","author":"WHO","year":"2015"},{"key":"10.1016\/j.ijid.2020.08.019_bib0275","series-title":"Global tuberculosis report 2019","author":"WHO","year":"2019"},{"issue":"2","key":"10.1016\/j.ijid.2020.08.019_bib0280","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.v22.i2.10","article-title":"Regulation of macrophage-derived chemokine (MDC\/CCL22) production","volume":"22","author":"Yamashita","year":"2002","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.ijid.2020.08.019_bib0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tube.2017.07.013","article-title":"Multiplex analysis of plasma cytokines\/chemokines showing different immune responses in active TB patients latent TB infection and healthy participants","volume":"107","author":"Yao","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijid.2020.08.019_bib0290","first-page":"10","article-title":"Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects","author":"Yong","year":"2019","journal-title":"Front Microbiol"},{"issue":"50","key":"10.1016\/j.ijid.2020.08.019_bib0295","doi-asserted-by":"crossref","first-page":"83051","DOI":"10.18632\/oncotarget.13031","article-title":"MDC and BLC are independently associated with the significant risk of early stage lung adenocarcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220306482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220306482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:55:36Z","timestamp":1761119736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220306482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":59,"alternative-id":["S1201971220306482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.08.019","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}